Effect of Probiotics on Atopic Dermatitis

Year 2013, Volume: 11 Issue: 1, 83 - 87, 01.03.2013

Aslı Akpınar A Sibel Akalın Harun Raşit Uysal

Abstract

The immune system protecting the body from pathogens is composed of both the innate and the adopted immune systems. Recently, allergies, a disease associated with an imbalanced immune system, have increased rapidly in developed countries. Prevailing symptoms of allergic diseases are eczema atopic dermatitis , allergic rhinitis, asthma, inflammatory bowel disease, and food allergy. Growing concern over the adverse immunologic effects of progressively more hygienic environments has led to enormous interest in the role of probiotics in the prevention and treatment of allergic disease. Probiotics are the live microbial feed supplements that beneficially affect the host animal by improving its intestinal microbial balance. Probiotics have been demonstrated to have anti-inflammatory properties. Although there are studies suggesting favorable effects of probiotics on allergic disease, the immune-regulatory impact of probiotic bacteria is controversial because it depends on probiotic strains, a dose and a type of diseases. This article reviews the studies related to the treatment and prevention of atopic dermatitis by probiotics

Keywords

Probiotics, Allergic diseases, Atopic dermatitis, Immune system

Probiyotiklerin Atopik Dermatit Üzerine Etkisi

Abstract

Vücudu patojenlere karşı koruyan bağışıklık sistemi, hem doğuştan gelen hem de sonradan kazanılan bağışıklık sistemlerinden oluşmaktadır. Son yıllarda özellikle gelişmiş ülkelerde bağışıklık sistemindeki dengenin bozulması sonucu ortaya çıkan alerjik hastalıklar hızla artış göstermektedir. En sık görülen alerji belirtileri, egzama atopik dermatit , bahar alerjisi, astım, iltihabi bağırsak hastalıkları ve gıda alerjileridir. Giderek daha fazla hijyenik ortamlara maruz kalma sonucunda bağışıklık sisteminin olumsuz etkilenmesi, alerjik rahatsızlıkların engellenmesinde ve tedavisinde probiyotiklere olan ilginin artmasını sağlamıştır. Probiyotikler insan ve hayvanların bağırsak mikrobiyal dengesini iyileştirerek yararlı etki gösteren canlı mikrobiyal gıda katkılarıdır. Probiyotiklerin antiinflamatuvar etki gösterdikleri belirlenmiştir. Ancak, her ne kadar probiyotiklerin alerjik rahatsızlıklar üzerinde olumlu etkilerini vurgulayan çalışmalar olsa da söz konusu bakterilerin bağışıklığı düzenleyici etkileri kullanılan bakteri türüne, sayısına ve hastalığın tipine bağlı olarak karışıklık göstermektedir. Bu derlemede probiyotiklerin atopik dermatitin engellenmesi ve tedavisi ile ilgili çalışmalar değerlendirilmiştir

Keywords

Probiyotikler, Alerjik hastalıklar, Atopik dermatit, Bağışıklık sistemi

References

• Yüksel, H., 2008. Alerjik Hastalıklar Nedir? Genel Bilgi. www.cocukalerjiklinigi.com
• Taylor, A.L., Dunstan, A.J., Prescott, S.L., 2007. Probiotics supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high risk children: A randomized controlled trail. Journal of Allergy Clinical Immunology 119(1):184-191.
• Viljanen, M., Pohjavuori E., Haahtela, T., Korpela, R., Kuitunen, M., Sarnesto, A., Vaarala, O. Savilahti, E. 2005. Induction of inflammation as a possible mechanism of probiotic effect in atopic eczama-dermatitis syndrome. Clinical Immunology 115(6):1254-1259.
• Zeyrek, F, Y., Zeyrek, C.D. 2006. Allerjik Hastalıklar ve Parazitos. Türkiye Parazitoloji Dergisi 30(2): 135- 140
• Kukkonen K, Savilahti E, Haahtela T, Juntunen- Backman K., Korpela R, Poussa T, Tuure T, Kuitunen M. 2007. Probiotics and prebiotic galacto- oligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo- controlled trial. Journal of Allergy Clinical Immunology 119(1):192-198.
• Prescott, L.S., Bjorksen, B. 2007. Probiotics for the prevention or treatment of allergic diseases. Journal of Allergy Clinical Immunology 120(2), 255-264.
• Grammer LC. 1997. Atopic dermatitis. In: Patterson R, Grammer LC, Greenberger PA (eds) Allergic Diseases. Diagnosis and management. 5. ed. Lippincott Raven. Philadelphia. pp: 305-10.
• Giudice, M.M., Rocco, A., Capristo, C. 2006. Probitics in the atopic march: highlights and new insights. Digestive and Liver Disease 38(2):288-290
• Sapan, N., Canıtez, Y. 2006. Atopik yürüyüş ve Alerjik hastalıklar. Güncel Pediatri 3: 124-125
• Uehara M, Kimura C. 1993. Descendant family history of atopic dermatitis. Acta Derm Venereol 73: 62–63.
• Leung, D.Y.M., 2004. Atopic dermatitis. In: Behrman RE, Kliegman RM, Jenson HB (eds) Nelson Textbook of Pediatrics. WB Saunders Philadelphia,17.ed. p;774-778.
• Sunada, Y., Nakamura, S., Kamei, C., 2008. Effect of Lactobacillus acidophilus strain L-55 on the development of atopic dermatitis-like skin lesions in NC/Nga mice. International Immunopharmacology 8: 1761–1766.
• Işık, F., Gönen, I., Gürsoy, O., Yapar, A., 2008. Atopik ekzamanın önlenmesi ve tedavisinde probiyotikler. Akademik Gıda 6(5): 36-44.
• Engin, B., Serdaroğlu, S. 2006. Atopik Ekzema ve Diyet kısıtlanması.Dermatose; 5(3) 181-185
• Bjorksten, B., Sepp, E., Julge, K., Voor, T., Mikelsaar, M., 2001. Allergy development and the intestinal microflora during the first year of life. Journal of Allergy Clinical Immunology 108: 516-20.
• Kalliomaki, M., Salminen, S., Arvilommi, H., 2001. Probiotics in primary prevention of atopic disease: a randomized placebo-controlled trial. Lancet 357: 1076-1079.
• Watanabe, S., Narisawa, Y., Arase, S., Okamatsu, H., Ikenaga, T., Tajiri, Y., 2003. Differences in fecal microflora between patients with atopic dermatitis and healthy control subjects. Journal of Allergy Clinical Immunology 111: 587-91.
• Roessler, A., Forssten, S.D., Glei, M., Ouwehand, A.C., Jahreis, G., 2012. The effect of probiotics on faecal microbiota and genotoxic activity of faecal water in patients with atopic dermatitis: A randomized, placebo-controlled study. Clinical Nutrition 31: 22-29.
• Penders, J., Thijs, C., Brandt, P.A., Kummeling, I., Snijders, B., Stelma, F., Adams, H., Ree, R., Stobberingh, E.E. Gut microbiota composition and development of atopic manifestations in infancy: the KOALA Birth Cohort Study. Gut 56: 661–667.
• Rhodes, H.L., Thomas, P., Sporik, R., et al. 2001. A birth cohort study of subjects at risk of atopy: twenty-two-year follow-up of wheeze ant atopic status. American Journal of Respiratory Critical Care Medicine 165:176-180.
• Kjellman, B., Hattevig, G., 1994. Allergy in early and late onset atopic dermatitis. Acta Pediatrica 83: 229- 231.
• İnanç, N., Şahin, H., Çiçek, B. 2005. Probiyotik ve Prebiyotiklerin İnsan Sağlığı Üzerine Etkileri. Erciyes Tıp Dergisi 27(3), 122-127
• Isolauri, E., 2001. Probiotics in human disease. American Journal of Clinical Nutrition 73: 1425 - 1465.
• Yılmaz, M., 2004. Prebiyotikler ve probiyotikler. Güncel Pediatri 2: 142-145
• Coşkun, T., 2006. Pro-, Pre- ve Sinbiyotikler. Çocuk Sağlığı ve Hastalıkları Dergisi 49: 128-148
• Dilnawaz, P., Shakeel, M., Ziyaurrahman, A.R., Tabreez, S., 2011. A review on probiotics. International Research Journal of Pharmacy. IRJP 2(7): 26-33
• Alm, L., 2009. Probiotics and human health. Akademik Gıda 7(5): 6-25.
• Murch, S.H. 2001. Toll of Allergy reduced by probiotics. Lancet 357: 1057-1059.
• Marsella, R., Santoro, D., Ahrens, K., 2012. Early exposure to probiotics in a canine model of atopic dermatitis has long-term clinical and immunological effects. Immunopathology (in Press). Immunology and
• Weese, J.S., Anderson, M.E., 2002. Preliminary evaluation of Lactobacillus rhamnosus strain GG (LGG), a potential probiotic in dogs. Canadian Veterinary Journal 43: 771–774.
• Marsella, R., 2009. Evaluation of Lactobacillus rhamnosus strain GG for the prevention of atopic dermatitis in dogs. American Journal of Veterinary Research 70: 735-740
• Bjorksten B, Naaber P, Sepp E. 1999. The intestinal microflora in allergic Estonian and Swedish 2-year old children. Clinical and Experimental Allergy 29: 342-346.
• Majamaa, H, Isolauri E., 1997. Probiotics: a novel approach in the management of food allrgy. Journal of Allergy and Clinical Immunology 99: 179-185.
• Matricardi, P.M., Bjorksten, B., Bonini, S., Bousquet, J., Djukanovic, R. Dreborg, S. Gereda, J., Malling, H.-J. Popov, T. Raz, E., Renz, H. 2003. Microbial products in allergy prevention and therapy. Allergy 58: 461–471.
• Ouwehand, A.C., 2007. Antiallergic Effects of Probiotics. Journal of Nutrition 137: 794-797.
• Lodinova-Zadnikova, R., Tlaskalova-Hogenova H., 2003. Oral administration of probiotic Escherichia coli after birth reduces frequency of allergies and repeated infections later in life (after 10 and 20 years). International Archives of Allergy and Immunology 131: 209-211. B.
• Kalliomaki, M., Salminen, S., Poussa, T., 2003. Probiotics and prevention of atopic disease: 4-year follow of a randomised placebo-controlled trial. Lancet 361: 1869-71
• López, P., Gueimonde, M., Margolles, A., Suárez, A., 2010. Distinct Bifidobacterium strains drive different immune responses in vitro. International Journal of Food Microbiology 138: 157–165.
• Rijkers, G.T., Bengmark, S., Enck, P., Haller, D., Herz, U., Kalliomaki, M., Kudo, S., Lenoir-Wijnkoop, I., Mercenier, A., Myllyluoma, E., Rabot, S., Rafter, J., Szajewska, H., Watzl, B., Wells, J., Wolvers, D., Antoine, J.M., 2010. Guidance for substantiating the evidence for beneficial effects of probiotics: current status and recommendations for future research. Journal of Nutrition 140: 671S–676S.
• van Hoffen, E., Korthagen, N.M., de Kivit, S., Schouten, B., Bardoel, B., Duivelshof, A., Knol, J., Garssen, J., Willemsen, L.E., 2010. Exposure of intestinal epithelial cells to UV-killed Lactobacillus GG but not Bifidobacterium breve enhances the effector immune response in vitro. International archives of allergy and Immunology 152: 159–168.
• Tang, M.L., Lahtinen, S.J., Boyle, R.J., 2010. Probiotics and prebiotics: clinical effects in allergic disease. Current Opinion Pediatrics 22: 626–634.